Volver
Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/87659
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPorta-Etessam, J
dc.contributor.authorGonzález-García, N
dc.contributor.authorGuerrero, Á L
dc.contributor.authorGarcía-Azorín, D
dc.date.accessioned2023-04-17T08:00:43Z-
dc.date.available2023-04-17T08:00:43Z-
dc.date.issued2021-07-08
dc.identifier.citationNeurologia (Engl Ed).2021;(36)8:638-640
dc.identifier.urihttps://hdl.handle.net/20.500.12530/87659-
dc.language.isoen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subject.meshAntibodies, Monoclonal
dc.subject.meshCalcitonin Gene-Related Peptide
dc.subject.meshCalcitonin Gene-Related Peptide Receptor Antagonists
dc.subject.meshPharmaceutical Preparations
dc.subject.meshReceptors, Calcitonin Gene-Related Peptide
dc.titleFailure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class.
dc.typeArtículo
dc.identifier.pubmedID34246579
dc.format.volume36
dc.format.page638-640
dc.identifier.e-issn2173-5808
dc.identifier.journalNeurologia (Barcelona, Spain)
dc.identifier.journalabbreviationNeurologia (Engl Ed)
dc.identifier.doi10.1016/j.nrleng.2020.10.008
dc.format.number8
dc.pubmedtypeLetter
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.
Show simple item record

Google Scholar ???export.bibtex.alt???


This item is licensed under a Creative Commons License Creative Commons